Ketamine: A Growing Concern in the UK’s Drug Landscape

Ketamine: A Growing Concern in the UK's Drug Landscape

Legal Status and Implications

The UK is currently facing a surge in the use of ketamine, a potent and fast-acting drug that has sparked concern among authorities and healthcare professionals. Classified as a class B drug in 2014, ketamine remains illegal to buy or sell, with stringent penalties in place—possession can lead to a maximum five-year prison sentence, while supplying the drug can result in up to 14 years of imprisonment.

Medical Uses and Misuse

Ketamine, often referred to as “K” or “ket,” is not solely a recreational substance. It plays a crucial role in medical settings as an anaesthetic in emergency medicine and in managing pain during end-of-life care. There is also ongoing research into its potential to treat certain types of depression. Despite these legitimate medical uses, non-medical use of ketamine is creating significant challenges.

Economic Factors and Market Dynamics

On the black market, ketamine is an affordable alternative to other drugs like cocaine and MDMA, costing approximately £20 per gram. While police forces report substantial seizures, global production remains high, and the wholesale price has decreased from £8,000 to £5,000 per kilogram. This price drop makes ketamine more accessible, especially appealing to young people and those with limited financial resources.

Health Risks and Effects

Ketamine use can lead to a range of effects, from euphoria and relaxation to dissociation, which at higher doses can result in panic attacks and memory issues. The drug also poses serious health risks, potentially affecting blood pressure, breathing, and heart function. There has been a noted rise in cases of “ketamine bladder,” a severe urinary condition linked to prolonged use, raising alarms in the medical community.

Rising Usage Among Youth

The recreational popularity of ketamine began in the 1990s, with usage among 16-24-year-olds in England and Wales increasing from 0.9% in 2006-07 to 3.8% in 2022-23, equating to about 220,000 individuals. This rise is mirrored by an increase in young people seeking treatment—512 entered treatment services in 2021-22, increasing to 719 in 2022-23. Adult treatment figures have similarly surged, growing fivefold since 2014.

Mental Health and Self-Medication

Experts suggest that the rise in ketamine use may be partly due to individuals with mental health issues self-medicating as they face long waiting times for professional care. Ketamine offers fast-acting relief from distressing symptoms, making it a tempting option for those seeking immediate respite. Its ready availability and lack of hangover effects typically associated with alcohol further enhance its appeal.

Preventing Future Impact

As the UK grapples with the escalating ketamine issue, it is important to focus on strategies that prevent drug use, particularly among young people. Enhanced public health messaging and improved access to mental health services are vital components in addressing this challenge. With a new government in power, there is an opportunity for policy shifts that could prioritise these areas, helping to alleviate suffering and protect lives.

Source: The Conversation

Leave a Reply

Your email address will not be published.